MetaCap

Who Owns Seaport Therapeutics Stock?

NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.05-0.27 (-1.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
73.44%
Institutional holders
94
  • Institutions 65.0%
  • Insiders 35.0%
  • Public and other 0.0%

Who owns Seaport Therapeutics stock?

Institutional investors own about 73.4% of Seaport Therapeutics's shares, spread across 94 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 34.99% of SPTX.

The largest institutional holders are Arch Venture Management, Llc (11.76%), General Atlantic, L.P. (11.40%) and Sofinnova Investments, Inc. (6.66%). Together, the top 10 institutions control 53.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their SPTX positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of SPTX

Seaport Therapeutics top institutional holders
InstitutionShares% HeldChange
Arch Venture Management, Llc6.29M11.76%+100.0%
General Atlantic, L.P.6.10M11.40%0.0%
Sofinnova Investments, Inc.3.56M6.66%+100.0%
Goldman Sachs Group Inc2.18M4.07%+100.0%
Trv Gp VI, LLC 2.06M3.85%+100.0%
Canada Pension Plan Investment Board1.98M3.69%+100.0%
FMR, LLC1.84M3.43%+55.1%
Foresite Capital Management VI LLC 1.78M3.32%+100.0%
JPMORGAN CHASE & CO1.60M2.98%-12.1%
Price (T.Rowe) Associates Inc1.31M2.44%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of SPTX

Seaport Therapeutics top fund holders
FundShares% Held
JPMorgan Trust II-JPMorgan Small Cap Growth Fund840.93K1.57%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund494.89K0.92%
Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund438.75K0.82%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund426.37K0.80%
iShares Trust-iShares Russell 2000 ETF355.16K0.66%
T. Rowe Price Health Sciences Fund, Inc.299.32K0.56%
JPMorgan Trust I-JPMorgan Small Cap Blend Fund271.50K0.51%
Fidelity Securities Fund-Fidelity Blue Chip Growth Fund235.90K0.44%
Principal Funds, Inc-SmallCap Fund181.50K0.34%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund165.44K0.31%

Frequently asked questions

Who is the largest shareholder of Seaport Therapeutics?

Arch Venture Management, Llc is the largest institutional shareholder of SPTX, owning 11.76% of shares outstanding (6.29M shares) as of its latest 13F filing.

What percentage of Seaport Therapeutics is owned by institutions?

Institutions own about 73.4% of SPTX shares and 113.0% of the public float.

How much of Seaport Therapeutics do insiders own?

Insiders, such as officers and directors, own about 34.99% of SPTX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related